Wolverine Trading
GBT

Wolverine Trading’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Wolverine Trading’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-9,500
Closed -$332K – 6181
2022
Q1 		$332K Buy
+9,500
New +$284K ﹤0.01% 3763
2021
Q3 		– Sell
-6,300
Closed -$204K – 7297
2021
Q2 		$204K Sell
6,300
-18,300
-74% -$714K ﹤0.01% 5001
2021
Q1 		$1M Sell
24,600
-2,800
-10% -$129K ﹤0.01% 2763
2020
Q4 		$1.21M Sell
27,400
-3,200
-10% -$158K ﹤0.01% 2185
2020
Q3 		$1.65M Buy
+30,600
New +$1.94M ﹤0.01% 1625
2020
Q2 		– Sell
-38,100
Closed -$1.98M – 5472
2020
Q1 		$1.98M Buy
38,100
+27,700
+266% +$1.86M 0.01% 1348
2019
Q4 		$823K Sell
10,400
-4,200
-29% -$249K ﹤0.01% 2598
2019
Q3 		$720K Sell
14,600
-8,700
-37% -$453K ﹤0.01% 2253
2019
Q2 		$1.23M Sell
23,300
-4,800
-17% -$276K ﹤0.01% 1873
2019
Q1 		$1.49M Sell
28,100
-14,300
-34% -$703K ﹤0.01% 1766
2018
Q4 		$1.7M Buy
42,400
+16,900
+66% +$633K ﹤0.01% 1549
2018
Q3 		$969K Buy
+25,500
New +$1.13M ﹤0.01% 2402

Other funds holding GBT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Wolverine Trading's GBT Position: Q3 2021 in Review

Wolverine Trading sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2021, closing a stake of 7,260 shares — an estimated $213K sold.

Wolverine Trading first reported a position in GBT in Q3 2018 and held it in 11 quarters. The position peaked at $1.44M in Q1 2020. 187 funds tracked by Wall St. Rank hold GBT as of Q3 2021.

  • Wolverine Trading reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2021 after selling out during the quarter.
  • Wolverine Trading sold 7,260 Global Blood Therapeutics, Inc. shares in Q3 2021, an estimated $213K.
  • Wolverine Trading first reported a position in Global Blood Therapeutics, Inc. in Q3 2018 and held it in 11 quarters.
  • Wolverine Trading's Global Blood Therapeutics, Inc. position peaked at $1.44M in Q1 2020.
  • 187 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2021.

Based on Wolverine Trading's 13F filing for Q3 2021, filed 12 Nov 2021.